Key result
Beta-blockers show efficacy and tolerability in elderly chronic heart failure patients despite widespread underuse.
Why the study?
Beta-blockers are effective and well tolerated in elderly patients with chronic heart failure but are substantially underutilized in clinical practice.
Are beta-blockers effective and well tolerated in elderly patients with chronic heart failure?
Population
Elderly patients with chronic heart failure
Comparison
Beta-blockers versus no beta-blockers or other treatments
Design
Review of published randomized trials and observational studies
Authors
Loading...
Beta-blockers remain underutilized in elderly CHF despite supporting evidence; leaves open optimal implementation strategies for practice and trials.
Are beta-blockers effective and well tolerated in elderly patients with chronic heart failure?
Despite evidence of efficacy and tolerability, beta-blockers remain underutilized in elderly patients with chronic heart failure.
Alberto De Bernardi (2009) conducted a review in Chronic heart failure (CHF). Beta-blockers was evaluated. A review of published trials suggests that beta-blockers are effective and well tolerated in elderly patients with chronic heart failure, despite being substantially underutilized in clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: